AstraZeneca's COVID-19 cocktail clears first step for registration in Australia

Australia's medical regulator said on Tuesday it had granted provisional determination to AstraZeneca for its antibody cocktail, the first protective shot other than vaccines against the COVID-19.

The Therapeutic Goods Administration added that the Anglo-Swedish drugmaker is now eligible to apply for provisional registration for the antibody cocktail, EVUSHELD, in Australia.

 

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)